BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33689884)

  • 1. TTK inhibitor promotes radiosensitivity of liver cancer cells through p21.
    Zhang H; Yao W; Zhang M; Lu Y; Tang J; Jiang M; Mou X; You G; Liang X
    Biochem Biophys Res Commun; 2021 Apr; 550():84-91. PubMed ID: 33689884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.
    Maachani UB; Kramp T; Hanson R; Zhao S; Celiku O; Shankavaram U; Colombo R; Caplen NJ; Camphausen K; Tandle A
    Mol Cancer Res; 2015 May; 13(5):852-62. PubMed ID: 25722303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.
    Maire V; Baldeyron C; Richardson M; Tesson B; Vincent-Salomon A; Gravier E; Marty-Prouvost B; De Koning L; Rigaill G; Dumont A; Gentien D; Barillot E; Roman-Roman S; Depil S; Cruzalegui F; Pierré A; Tucker GC; Dubois T
    PLoS One; 2013; 8(5):e63712. PubMed ID: 23700430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TC Mps1 12, a novel Mps1 inhibitor, suppresses the growth of hepatocellular carcinoma cells via the accumulation of chromosomal instability.
    Choi M; Min YH; Pyo J; Lee CW; Jang CY; Kim JE
    Br J Pharmacol; 2017 Jun; 174(12):1810-1825. PubMed ID: 28299790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability.
    Stratford JK; Yan F; Hill RA; Major MB; Graves LM; Der CJ; Yeh JJ
    PLoS One; 2017; 12(4):e0174863. PubMed ID: 28380042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.
    Wei JH; Chou YF; Ou YH; Yeh YH; Tyan SW; Sun TP; Shen CY; Shieh SY
    J Biol Chem; 2005 Mar; 280(9):7748-57. PubMed ID: 15618221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.
    Szymiczek A; Carbone M; Pastorino S; Napolitano A; Tanji M; Minaai M; Pagano I; Mason JM; Pass HI; Bray MR; Mak TW; Yang H
    Oncogene; 2017 Nov; 36(46):6501-6507. PubMed ID: 28759042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell lines.
    Libouban MAA; de Roos JADM; Uitdehaag JCM; Willemsen-Seegers N; Mainardi S; Dylus J; de Man J; Tops B; Meijerink JPP; Storchová Z; Buijsman RC; Medema RH; Zaman GJR
    Oncotarget; 2017 Jun; 8(24):38309-38325. PubMed ID: 28415765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer.
    Miao R; Wu Y; Zhang H; Zhou H; Sun X; Csizmadia E; He L; Zhao Y; Jiang C; Miksad RA; Ghaziani T; Robson SC; Zhao H
    Sci Rep; 2016 Sep; 6():33121. PubMed ID: 27618777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells.
    Nojima H; Homma H; Onozato Y; Kaida A; Harada H; Miura M
    Exp Cell Res; 2020 Jan; 386(2):111720. PubMed ID: 31738907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells.
    Liu X; Liao W; Yuan Q; Ou Y; Huang J
    Oncotarget; 2015 Oct; 6(33):34309-20. PubMed ID: 26418879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NU7441 Enhances the Radiosensitivity of Liver Cancer Cells.
    Yang C; Wang Q; Liu X; Cheng X; Jiang X; Zhang Y; Feng Z; Zhou P
    Cell Physiol Biochem; 2016; 38(5):1897-905. PubMed ID: 27160694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK/hMps1.
    Yeh YH; Huang YF; Lin TY; Shieh SY
    Oncogene; 2009 Mar; 28(10):1366-78. PubMed ID: 19151762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination.
    Chandler BC; Moubadder L; Ritter CL; Liu M; Cameron M; Wilder-Romans K; Zhang A; Pesch AM; Michmerhuizen AR; Hirsh N; Androsiglio M; Ward T; Olsen E; Niknafs YS; Merajver S; Thomas DG; Brown PH; Lawrence TS; Nyati S; Pierce LJ; Chinnaiyan A; Speers C
    J Clin Invest; 2020 Feb; 130(2):958-973. PubMed ID: 31961339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition.
    Jemaà M; Manic G; Lledo G; Lissa D; Reynes C; Morin N; Chibon F; Sistigu A; Castedo M; Vitale I; Kroemer G; Abrieu A
    Oncotarget; 2016 Jan; 7(1):885-901. PubMed ID: 26637805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
    Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
    Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.
    Thu KL; Silvester J; Elliott MJ; Ba-Alawi W; Duncan MH; Elia AC; Mer AS; Smirnov P; Safikhani Z; Haibe-Kains B; Mak TW; Cescon DW
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1570-E1577. PubMed ID: 29378962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer.
    Mason JM; Wei X; Fletcher GC; Kiarash R; Brokx R; Hodgson R; Beletskaya I; Bray MR; Mak TW
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3127-3132. PubMed ID: 28270606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of
    Tsai YM; Wu KL; Chang YY; Hung JY; Chang WA; Chang CY; Jian SF; Tsai PH; Huang YC; Chong IW; Hsu YL
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.